Z-domain of protein A scaffold protein anti-Staphylococcus aureus Protein A

CAT#: SZA-L237

This protein A specific binding protein (Z-domain of protein A) was investigated by an α-helix shuffling strategy. The primary scaffold protein was from a naive combinatorial library of the three-helix bundle Z domain derived from staphylococcal protein A. A hierarchical library was constructed through selective re-randomization of six amino acid positions in one of the two α-helices of the domain, making up the Taq DNA polymerase binding surface. After selections using monovalent phage display technology, second generation variants were identified having affinities (KD=20 nM) for protein A as determined by biosensor technology. It's potential to be used in diagnostic, research and therapeutic applications.

Specifications

  • Scaffold Name
  • Z-domain of protein A
  • Origin
  • Staphylococcal protein A
  • Core Structure
  • 3-α helixes
  • Variable Regions
  • 13 Residues on first and second helix surface
  • Target
  • Protein A
  • Species Reactivity
  • Staphylococcus aureus
  • Expression Host
  • E. coli
  • Affinity Constant
  • 20 nM
  • Applications
  • ELISA; IHC; Microscopy; FC; WB; FuncS

Target

  • Alternative Names
  • Staphylococcal protein A; Z-domain of protein A; repA; replication initiator protein A; protein A
REVIEWS AND Q&AS CITATIONS RESOURCES DOWNLOADS RELATED PRODUCTS
Inquiry
Navs

Customer Review

Submit a review or a question

There are currently no Customer reviews or questions for SZA-L237. Click the button above to contact us or submit your feedback about this product.
Breast cancer biomarkers at key points during disease progression
Validated By Phage Display
Knowing this protein was selected using monovalent phage display technology gave us confidence in its specificity. Our ELISA results confirmed it binds the target successfully, validating the helix shuffling strategy employed during its development.
Breast cancer biomarkers at key points during disease progression
Impressive Affinity Maturation
The hierarchical library construction used to create this variant evidently paid off. We measured the affinity for Protein A and confirmed the KD was approximately 20 nM, which is significantly tighter than some first-generation scaffolds we have tested previously.

Q&As

  1. How does this variant differ in affinity from early generations?

    A: Through the construction of a hierarchical library and selective re-randomization, second-generation variants were identified with significantly improved binding. Specifically, this product has an affinity (KD=20 nM) for protein A as determined by biosensor technology.

  2. What structural strategy was used to investigate this protein?

    A: This protein A specific binding protein was investigated by an alpha-helix shuffling strategy. The primary scaffold is based on the three-helix bundle Z domain derived from staphylococcal protein A, with re-randomization of positions making up the Taq DNA polymerase binding surface.

View the frequently asked questions answered by Creative Biolabs Support.

Submit Your Publication

Published with our product? Submit your paper and receive a 10% discount on your next order! Share your research to earn exclusive rewards.

Article title:
DOI/PubMed URL:
Email:
Name:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Downloadable Resources

Download resources about recombinant antibody development and antibody engineering to boost your research.

Datasheet

MSDS

COA

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number:

See other products for "repA"

Select a product category from the dropdown menu below to view related products.

CAT Product Name Application Type
VS-0625-FY1042 Mouse Anti-repA Recombinant Antibody (clone 2506W0937) ELISA Mouse IgG
Specific Inquiry
Go to compare Add to compare

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Go to compare

Go to compare